Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Mark Pettus MD and John Bagnulo PhD, MPH, Mark Pettus MD, John Bagnulo PhD, and MPH. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mark Pettus MD and John Bagnulo PhD, MPH, Mark Pettus MD, John Bagnulo PhD, and MPH or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Coffee, AFib, And What The Science Says

35:04
 
Share
 

Manage episode 523762358 series 3493259
Content provided by Mark Pettus MD and John Bagnulo PhD, MPH, Mark Pettus MD, John Bagnulo PhD, and MPH. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mark Pettus MD and John Bagnulo PhD, MPH, Mark Pettus MD, John Bagnulo PhD, and MPH or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text

Coffee and heart rhythm don’t have to be enemies. We dig into a new randomized trial across the US, Canada, and Australia suggesting that caffeinated coffee may lower the risk of recurrent atrial fibrillation compared with abstaining, then connect the dots with real-world monitoring, ablation strategy, and day-to-day choices that influence heart health.
We start by grounding AFib in plain terms: what it is, why so many people never feel it, and how stroke risk rises when the atria stop driving a steady beat. From there, we step into the electrophysiology lab to explain why trouble often starts near the pulmonary veins and how clinicians map and ablate rogue electrical tissue. Along the way, we highlight the role of wearables like Apple Watch in catching silent arrhythmias and guiding decisions, a shift that is rapidly improving detection and management outside the clinic.
Then we unpack the DECAF trial’s headline: coffee drinkers showed meaningfully lower recurrence of AFib or flutter over six months versus those who abstained. We explore possible reasons, from caffeine’s adenosine receptor antagonism and calcium signaling effects to the antioxidant and mitochondrial support offered by coffee’s polyphenols. We also compare with NEJM data in the general population showing no significant increase in ectopy, putting fears into perspective. Finally, we get practical: dosing and timing to protect sleep, what brewing methods change, how dairy proteins can blunt polyphenol absorption, and when unfiltered versus filtered makes sense if you’re balancing lipids and antioxidants.
If you enjoy coffee and live with AFib, these insights can help you personalize your cup without losing sight of the fundamentals: anticoagulation when indicated, smart rate or rhythm control, and balanced training that avoids chronic overload. If this conversation helps you think differently about caffeine, subscribe, share with someone who cares about heart health, and leave a review so others can find it.

For powerpoint slide deck, video recording and reference open-source articles go to: www.thehealthedgepodcast.com

  continue reading

Chapters

1. Opening And Today’s Big Question (00:00:00)

2. Coffee’s Reputation Versus New Evidence (00:00:20)

3. AFib Basics And Hidden Risks (00:03:32)

4. Unique AFib Cohorts And Mechanisms (00:06:05)

5. EP Insights And Pulmonary Vein Focus (00:11:40)

6. How Ablation Works (00:14:24)

7. Reading Rhythms And AFib On Devices (00:17:24)

8. The DCAF Randomized Trial Results (00:18:36)

9. Adenosine, Caffeine, And Rate Control (00:21:05)

10. Population Data From NEJM (00:24:35)

11. Coffee, Lipids, And Mitochondria (00:27:00)

12. Dose, Sleep, And Practical Caveats (00:29:05)

13. Brewing Methods, Dairy, And Polyphenols (00:31:20)

14. Closing Notes And What’s Next (00:33:00)

53 episodes

Artwork
iconShare
 
Manage episode 523762358 series 3493259
Content provided by Mark Pettus MD and John Bagnulo PhD, MPH, Mark Pettus MD, John Bagnulo PhD, and MPH. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mark Pettus MD and John Bagnulo PhD, MPH, Mark Pettus MD, John Bagnulo PhD, and MPH or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text

Coffee and heart rhythm don’t have to be enemies. We dig into a new randomized trial across the US, Canada, and Australia suggesting that caffeinated coffee may lower the risk of recurrent atrial fibrillation compared with abstaining, then connect the dots with real-world monitoring, ablation strategy, and day-to-day choices that influence heart health.
We start by grounding AFib in plain terms: what it is, why so many people never feel it, and how stroke risk rises when the atria stop driving a steady beat. From there, we step into the electrophysiology lab to explain why trouble often starts near the pulmonary veins and how clinicians map and ablate rogue electrical tissue. Along the way, we highlight the role of wearables like Apple Watch in catching silent arrhythmias and guiding decisions, a shift that is rapidly improving detection and management outside the clinic.
Then we unpack the DECAF trial’s headline: coffee drinkers showed meaningfully lower recurrence of AFib or flutter over six months versus those who abstained. We explore possible reasons, from caffeine’s adenosine receptor antagonism and calcium signaling effects to the antioxidant and mitochondrial support offered by coffee’s polyphenols. We also compare with NEJM data in the general population showing no significant increase in ectopy, putting fears into perspective. Finally, we get practical: dosing and timing to protect sleep, what brewing methods change, how dairy proteins can blunt polyphenol absorption, and when unfiltered versus filtered makes sense if you’re balancing lipids and antioxidants.
If you enjoy coffee and live with AFib, these insights can help you personalize your cup without losing sight of the fundamentals: anticoagulation when indicated, smart rate or rhythm control, and balanced training that avoids chronic overload. If this conversation helps you think differently about caffeine, subscribe, share with someone who cares about heart health, and leave a review so others can find it.

For powerpoint slide deck, video recording and reference open-source articles go to: www.thehealthedgepodcast.com

  continue reading

Chapters

1. Opening And Today’s Big Question (00:00:00)

2. Coffee’s Reputation Versus New Evidence (00:00:20)

3. AFib Basics And Hidden Risks (00:03:32)

4. Unique AFib Cohorts And Mechanisms (00:06:05)

5. EP Insights And Pulmonary Vein Focus (00:11:40)

6. How Ablation Works (00:14:24)

7. Reading Rhythms And AFib On Devices (00:17:24)

8. The DCAF Randomized Trial Results (00:18:36)

9. Adenosine, Caffeine, And Rate Control (00:21:05)

10. Population Data From NEJM (00:24:35)

11. Coffee, Lipids, And Mitochondria (00:27:00)

12. Dose, Sleep, And Practical Caveats (00:29:05)

13. Brewing Methods, Dairy, And Polyphenols (00:31:20)

14. Closing Notes And What’s Next (00:33:00)

53 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play